Sunday - November 15, 2026
Roche Strengthens Cancer Diagnostic Portfolio With Launch of Test for Differential Diagnosis of Mesothelioma
October 29, 2026
BASEL, Switzerland, Oct. 29 (TNSjou) -- Roche, a biotech company, issued the following news release:

* * *

Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

October 28, 2026

* The VENTANA BAP1 (SP527) test helps confidently distinguish malignant mesothelioma from lung, breast and stomach cancers, as well as benign tissue growth in the chest or abdomen.

* Most patients are d . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products